Egyptian International Pharmaceutical Industries Company (EGX: PHAR)

PHAR Revenue

Egyptian International Pharmaceutical Industries Company had revenue of 2.07B EGP in the quarter ending September 30, 2024, with 46.69% growth. This brings the company's revenue in the last twelve months to 7.00B, up 41.49% year-over-year. In the year 2023, Egyptian International Pharmaceutical Industries Company had annual revenue of 5.23B with 32.27% growth.

• Revenue (ttm): 7.00B
• Revenue Growth: +41.49%
• P/S Ratio: 1.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 7.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.23B	1.28B	32.27%
Dec 31, 2022	3.96B	546.35M	16.03%
Dec 31, 2021	3.41B	523.18M	18.13%
Dec 31, 2020	2.89B	-525.41M	-15.40%
Dec 31, 2019	3.41B	595.47M	21.15%